Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



Hindustan Syringes And Medical Devices (HMD) To Invest Over Rs.100 Crore To Ramp Up Syringe Production

With the surge in Covid cases amid the rising demand for syringes during the ongoing vaccination drive in India, Hindustan Syringes and Medical Devices (HMD) on Sunday said that the company will invest over ?100 crore to expand its production capacity from 2.5 billion syringes to over 3 billion.

Rajiv Nath, Managing Director, HMD told that the company not only needs to invest in production lines of syringes-moulds, moulding machines, printing and assembly packaging, etc. but also in needle assembly, needles point grinding, recruiting workers and training them.

"Our current production capacity is over 2.7 billion syringes per annum of disposable and auto-disable syringes are approximately 90 lakhs daily. And we are investing over ?100 crore to ramp up capacity from 2.5 billion syringes to over 3 billion by next quarter," Nath informed.

According to Nath, HMD has been practicing the government's 'Atmanirbhar Bharat' initiative for decades by making their components.

"We do share the Prime Minister's vision and quest for an Atmanirbhar Bharat. It is in our DNA," Nath said.

"It is another matter that government policies in the last 10 years favour imports of medical devices and components. So it's no more a competitive advantage to produce these components in India," he added.

The company said that it is also facing few challenges in the process of production and supply due to the pandemic.

The company has received orders for 240 million Kojak syringes for COVAX via UNICEF and 79 million for Brazil for Dispovan syringes via PAHO.

"We had also shipped 140 million Kojak syringes to Covid-19 Vaccine Global Access (COVAX) last December. We have recently sold 15 million syringes to the Japanese government. In total, we serve over 120 countries worldwide," he said.


Medtronic Opens Engineering, Innovation Centre In Hyderabad

Medtech player to strengthen its R&D facility.

Medtronic pls, global player in medical technology, has set up its new Medtronic Engineering and Innovation Center (MEIC) here. The 150,000 sq ft centre employs engineers currently in the areas of software development and testing, test automation, mechanical design, analysis and hardware was formally inaugurated by KT Rama Rao, Minister for Municipal Administration & Urban Development, Industries & Commerce, and Information Technology, Government of Telangana here on Wednesday.

“We see enormous potential in energising the medical devices innovation ecosystem in the country. The R&D team in India is a key contributor to Medtronic’s global product development,’’ Madan Krishnan, Vice-President and Managing Director, India Medtronic Pvt Ltd, said in the inaugural function.

“The opening of the new site is an important milestone for us as it serves as a critical component in strengthening our global R&D organisation and will also drive innovation and growth,’’ he added.

Globally, Medtronic has spent approximately $2.3 billion annually in R&D in recent years, and MEIC recently received an investment of ?1,200 crore for expansion in Hyderabad.

This investment planned over five years aims to foster global innovation and create several job opportunities. With this expansion, MEIC aims to leverage the sizeable pool of diverse and skilled talent in India.

Rama Rao said: “Hyderabad is already home to marquee technology and life sciences companies and now, we are extremely delighted to host the largest R&D facility for Medtronic outside the US.’’

Medical devices sector has been identified as one of the key focus sectors by the State, he added.

MEIC serves as a global hub for development, testing and qualification for some of the most advanced and innovative technologies. The setting up of the new R&D facility is a step to create synergy by supporting Medtronic’s businesses globally, in various therapy areas including respiratory intervention, remote patient monitoring and digital health, surgical robotics, electrosurgical generators, cardiac rhythm and heart failure, and navigation, amongst others.

Other News

Milacron Expands Line of Electric Injection Molding Machines
PLI Scheme Incentive Rate For Medical Sector Should Be Revised To 10%: Transasia
MTaI Seeks Relook At Revised Public Procurement Order On Medical Devices





Back | Back To Top | Previous | Next